Ann: September 2020 Quarterly Update and Appendix 4C, page-22

only just had a chance to read the update.

well it's good that the COVID results will hopefully be released next month, the pleasing thing for me was that PTX-100 and PTX-200 are continuing with results "in the coming quarters". This of course could mean this quarter, but I'm guessing early in the new year for PTX-100.

I also did like this part in relation to PTX-100. Global interest in the program is driven by the fact that although these two mutations are present in multiple cancers, there is currently no approved therapy able to address the urgent needs of patients with these cancers.

SP is obviously frustratingly disappointing, but obviously that's what happens with limited news flow.